BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 20031112)

  • 1. Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.
    Rodriguez MI; Warden M; Darney PD
    Am J Obstet Gynecol; 2010 May; 202(5):420-8. PubMed ID: 20031112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L; Bahamondes MV; Monteiro I
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
    Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
    Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
    Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
    Maruo T; Ohara N; Yoshida S; Nakabayashi K; Sasaki H; Xu Q; Chen W; Yamada H
    Contraception; 2010 Nov; 82(5):435-41. PubMed ID: 20933117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future medical treatments for menometrorrhagia during the premenopause.
    Bouchard P
    Gynecol Endocrinol; 2011 Dec; 27 Suppl 1():1120-5. PubMed ID: 22182055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
    Bouchard P; Chabbert-Buffet N; Fauser BC
    Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
    Talaulikar VS; Manyonda I
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):135-40. PubMed ID: 22901974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective progesterone receptor modulators: future clinical applications].
    Bouchard P; Ouzounian S; Chabbert-Buffet N
    Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.
    Chrisman C; Ribeiro P; Dalton VK
    Clin Obstet Gynecol; 2007 Dec; 50(4):886-97. PubMed ID: 17982331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
    Varma R; Sinha D; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):9-28. PubMed ID: 16325993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD; Gueye NA
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of progesterone receptor modulators and their effect on the endometrium.
    Spitz IM
    Curr Opin Obstet Gynecol; 2009 Aug; 21(4):318-24. PubMed ID: 19602929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
    Milsom I
    Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?
    Donnez J; Donnez O; Dolmans MM
    Fertil Steril; 2014 Sep; 102(3):640-8. PubMed ID: 25106762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
    Mansour D
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):1007-21. PubMed ID: 17544330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiprogestins on the uterus.
    Ouzounian S; Bouchard P; Chabbert-Buffet N
    Womens Health (Lond); 2008 May; 4(3):269-80. PubMed ID: 19072476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of menorrhagia.
    Apgar BS; Kaufman AH; George-Nwogu U; Kittendorf A
    Am Fam Physician; 2007 Jun; 75(12):1813-9. PubMed ID: 17619523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.